Dr. Brannigan on genetic evaluation of the infertile male

Data demonstrated wide variation in the proportion of patients recommended for testing and showed that barriers to testing remain.

In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.

“It is critical that urologists understand when to order germline testing, are comfortable with actually ordering these tests, and integrate medical geneticists when appropriate," says Aditya Bagrodia, MD, FACS.

In this podcast episode, Adam B. Murphy, MD, MBA, MSCI, discusses the need to increase diversity in clinical trials, specifically focusing on studies in prostate cancer.

Patients with elevated CTC count at baseline experienced poor complete response rates and worsened PFS and OS.

No patients in the transperineal cohort experienced an infection, compared with 1.6% of patients in the transrectal cohort.